Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients. (6th November 2014) - Pico de Coaña, Yago; Poschke, Isabel; Yoshimoto, Yuya; Karlberg, Sara; Nyström, Maria; Wolodarski, Maria; Hansson, Johan; Masucci, Giuseppe; Kiessling, Rolf